|
|
| On Line Home Study Programs |
|
Overview of Invasive Fungal Infections and Antifungal Therapies
Program Overview
This program is an overview of systemic fungal infections and the agents used used as treatment options.
Presentation
Program Information
- Target Audience
All Registered Pharmacists.
This program is not accredited for Pharmacy Technicians.
- Learning Objectives
After participating in this program, the pharmacist should be able to:
- Recognize changes in antifungal therapy based on etiology, incidence, diagnosis and treatment of invasive fungal pathogens.
- Compare and contrast the spectrum, biopharmaceutical properties, and role of newer azoles and echinocandin antifungal agents versus established antifungal therapies.
- Assess the strengths and limitations of current treatment approaches and guidelines for the management of invasive candidiasis and invasive mould infections.
- Discuss combination therapy and other salvage antifungal strategies for patients who fail to respond to first-line antifungal agents.
Program Faculty
- Faculty Disclosure Statement
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, Northeastern University Bouvé College of Health Sciences School of Pharmacy requires that faculty members disclose any relationship (e.g., shareholder, recipient of research grant, consultant, or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on faculty presentations.
- Faculty and Disclosure Information
Steven Gabardi, PharmD, BCPS
Renal Transplant Clinical Specialist
Brigham and Women's Hospital
Assistant Clinical Professor
Northeastern University
Bouvé College of Health Sciences
School of Pharmacy
Boston, Massachusetts
- Grant/Research Support
- Astellas Pharma US Inc.
- Schering-Plough Corporation
- Speaker with Honorarium
Dr. Gabardi plans on discussing unlabeled/investigational uses of a commercial product.
Program Support
This program is supported by an educational grant from Astellas Pharma US Inc.
There is no fee for this program.
Continuing Education Accreditation Information
Northeastern University Bouvé College of Health Sciences School of Pharmacy is approved by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. Pharmacists successfully participating in this program will receive a statement of credit for one contact hour (0.1 CEU). Statements of Credit may be printed on-line after successful completion of the learning assessment (70%).
ACPE # 027-000-06-040-H01. Initial release date: March 1, 2006, expires March 1, 2009
Further Disclosure of Unlabeled Use and Disclaimer
|
|
|
